HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts.

AbstractBACKGROUND:
Neutrophil adhesion is initiated by the interaction of rapidly expressed endothelial selectins with oligosaccharide structures (sialyl Lewis(x) on polymorphonuclear neutrophils (PMN). The carbohydrate sialyl Lewis X analogue CY-1503 blocks selectin receptors, thereby inhibiting PMN rolling and subsequent firm adhesion and migration.
METHODS:
We evaluated the inhibitory effect of CY-1503 on PMN migration and reperfusion injury in canine left lung allografts. Donor lungs were flushed with modified Euro-Collins solution (1500 ml, 4 degrees C) and preserved for 21 hours at 1 degree C. Left lung allotransplantation was subsequently performed in 14 mongrel dogs. Immediately after transplantation and allograft reperfusion, the recipient contralateral right pulmonary artery and bronchus were ligated to permit assessment of isolated allograft function during a 6-hour postreperfusion period (FIO2 = 1.0). Allograft gas exchange (q 15 minutes) and hemodynamics (q 60 minutes) were assessed. After sacrifice, allograft bronchoalveolar lavage fluid (BALF) PMN count and allograft tissue myeloperoxidase (MPO) activity were measured. Two groups were studied: In group I (n = 7) CY-1503 was added to the donor lung flush (20 mg/L) and given to the recipient (35 mg/kg intravenous bolus) before reperfusion, followed by a continuous infusion (5.25 mg/kg/h intravenously) during the 6-hour assessment period. Group II animals (n = 7) received no CY-1503.
RESULTS:
Gas exchange in group I was superior throughout the assessment period (p < 0.01 at 6 hours after reperfusion). BALF PMN count in group I was reduced to 0.57 +/- 0.3 x 10(6) PMN/ml compared with 3.9 +/- 1.3 x 10(6) PMN/ml in group II (p < 0.05). Group I allograft MPO activity was 0.21 +/- 0.06 compared with 0.40 +/- 0.02 delta OD/mg/ min in controls (p < 0.02). Two animals in each group died early after reperfusion as a result of graft failure and were excluded from analysis.
CONCLUSIONS:
Our observations indicate that selectin inhibition effectively reduces PMN adhesion, migration, and subsequent reperfusion injury in preserved canine lung allografts.
AuthorsR A Schmid, M Yamashita, C H Boasquevisque, K Ando, S Fujino, L Phillips, J D Cooper, G A Patterson
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 16 Issue 10 Pg. 1054-61 (Oct 1997) ISSN: 1053-2498 [Print] United States
PMID9361248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CY 1503
  • Euro-Collins' solution
  • Hypertonic Solutions
  • Oligosaccharides
  • Organ Preservation Solutions
  • Selectins
  • Peroxidase
Topics
  • Animals
  • Bronchoalveolar Lavage Fluid (cytology)
  • Cause of Death
  • Cell Adhesion (drug effects)
  • Cell Movement (drug effects)
  • Chemotaxis, Leukocyte (drug effects)
  • Dogs
  • Endothelium, Vascular (drug effects, metabolism)
  • Graft Survival
  • Hemodynamics (physiology)
  • Hypertonic Solutions (therapeutic use)
  • Infusions, Intravenous
  • Injections, Intravenous
  • Leukocyte Count
  • Lung (enzymology)
  • Lung Transplantation (pathology, physiology)
  • Neutrophils (drug effects)
  • Oligosaccharides (therapeutic use)
  • Organ Preservation
  • Organ Preservation Solutions (therapeutic use)
  • Peroxidase (metabolism)
  • Pulmonary Gas Exchange (physiology)
  • Reperfusion Injury (prevention & control)
  • Selectins (drug effects)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: